Skip to main content
Clinical Trials/EUCTR2015-000051-24-FI
EUCTR2015-000051-24-FI
Active, not recruiting
Not Applicable

The pharmacokinetics and –genomics of remifentanil, and its effects on the depth-of-anaesthesia monitors and the protein synthesis in children.

Klaus Olkkola/University of Helsinki0 sitesJanuary 23, 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Klaus Olkkola/University of Helsinki
Status
Active, not recruiting
Last Updated
10 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 23, 2015
End Date
TBD
Last Updated
10 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Klaus Olkkola/University of Helsinki

Eligibility Criteria

Inclusion Criteria

  • Patient is 3\-15 years old (body weight (15\-61 kg). Patients ASA class is 1\-2\. Patient comes to an elective surgery which necessitates general anesthesia. Operation time is appr. 1\.5\-6 hours
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 60
  • F.1\.2 Adults (18\-64 years) no
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Patient has a disease or trauma affecting the state of consciousnes or encephaloelectrogram measurement. Patient comes to a head or neck surgery. Anaesthesia cannot be induced via intravenous route. The researchers cannot place the second iv\-cannula. Muscle relaxant is needed. Patient or his/her guardians refuse to take part in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials